共 7 条
[1]
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. Morris M,Eifel PJ,Lu J,et al. The New England Journal of Medicine . 1999
[2]
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Monk BJ,Cha DS,Walker JL,et al. Gynecologic Oncology . 1994
[3]
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and metaanalysis. Green JA,Kirwan JM,Tierney JF,et al. The Lancet . 2001
[4]
Randomized comparison of uorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Whitney CW,Sause W,Bundy BN,et al. Journal of Clinical Oncology . 1999
[5]
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Peters WA 3 rd,Liu PY,Barrett RJ 2nd,et al. Journal of Clinical Oncology . 2000
[6]
Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. Keys HM,Bundy BN,Stehman FB, et al. The New England Journal of Medicine . 1999
[7]
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Rose P G,Bundy B N,Watkins E B,et al. The New England Journal of Medicine . 1999